Gene therapy for cystic fibrosis: 15-Year safety watch begins
NCT ID NCT06962852
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study follows 5 people with cystic fibrosis who previously received a single dose of BI 3720931 gene therapy or placebo. No new treatment is given. Researchers will check for long-term side effects and track lung function over up to 15 years to see if the therapy remains effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Universitari Vall d'Hebron
Barcelona, 08035, Spain
-
Hôpital Gui de Chauliac
Montpellier, 34295, France
-
Osp. Pediatrico Bambin Gesù
Roma, 00165, Italy
-
Royal Brompton Hospital
London, SW3 6JY, United Kingdom
-
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX, Netherlands
Conditions
Explore the condition pages connected to this study.